Galecto Inc
NASDAQ:GLTO
Galecto Inc
Cash from Financing Activities
Galecto Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
Cash from Financing Activities
$2.9m
|
CAGR 3-Years
-75%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Cash from Financing Activities
-kr606m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Cash from Financing Activities
kr907m
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Cash from Financing Activities
€134.3m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Cash from Financing Activities
kr735.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
Bioporto A/S
CSE:BIOPOR
|
Cash from Financing Activities
kr40.8m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-2%
|
See Also
What is Galecto Inc's Cash from Financing Activities?
Cash from Financing Activities
2.9m
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Cash from Financing Activities amounts to 2.9m USD.
What is Galecto Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-42%
Over the last year, the Cash from Financing Activities growth was 464%. The average annual Cash from Financing Activities growth rates for Galecto Inc have been -75% over the past three years , -42% over the past five years .